U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07602205) titled 'Efficacy and Safety of Daily Home-based Hyperthermic Baths for Reducing Epileptic Seizures in CDKL5 Deficiency Disorder: A PROBE Clinical Trial' on May 15.
Brief Summary: The primary objective of this research is to study the efficacy and safety of daily, home-based hyperthermic baths for reducing epileptic seizures in CDKL5 Deficiency Disorder.
Study Start Date: Aug. 01, 2026
Study Type: INTERVENTIONAL
Condition:
CDKL5 Deficiency Disorder
Intervention:
BEHAVIORAL: Home-based hyperthermic Baths
A 12-week daily home-based hyperthermic bathing intervention consisting of immersion in a 40-42degC water bath for 20 minutes per sess...